Amylyx Pharmaceuticals IncNASDAQ:AMLX
- LAST PRICE3.1200
- TODAY'S CHANGE (%)0.1100 (3.6545%)
- Bid / Lots3.0600/ 10
- Ask / Lots3.1300/ 1
- Open / Previous Close3.0000 / 3.0100
- Day Range
- 52 Week Range
- Volume1,761,397
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 6331 | 2.98 |
| 09:34 ET | 2148 | 2.9767 |
| 09:36 ET | 1000 | 2.971 |
| 09:38 ET | 1541 | 2.981 |
| 09:39 ET | 540 | 2.99 |
| 09:41 ET | 6768 | 2.985 |
| 09:43 ET | 2934 | 3.005 |
| 09:45 ET | 550 | 3.02 |
| 09:48 ET | 2688 | 3.01 |
| 09:50 ET | 21360 | 3.025 |
| 09:52 ET | 1997 | 3.0201 |
| 09:54 ET | 1300 | 3.025 |
| 09:56 ET | 2914 | 3.025 |
| 09:57 ET | 9133 | 3.035 |
| 09:59 ET | 3154 | 3.0311 |
| 10:01 ET | 14933 | 3.045 |
| 10:03 ET | 500 | 3.045 |
| 10:06 ET | 1272 | 3.043052 |
| 10:08 ET | 1562 | 3.045 |
| 10:10 ET | 3985 | 3.045 |
| 10:12 ET | 10490 | 3.05 |
| 10:14 ET | 964 | 3.06 |
| 10:15 ET | 1500 | 3.065 |
| 10:17 ET | 5045 | 3.085 |
| 10:19 ET | 33730 | 3.085 |
| 10:21 ET | 11655 | 3.09 |
| 10:24 ET | 792 | 3.0813 |
| 10:26 ET | 589 | 3.085 |
| 10:28 ET | 8575 | 3.07 |
| 10:30 ET | 1694 | 3.085 |
| 10:32 ET | 1300 | 3.09 |
| 10:33 ET | 100 | 3.09 |
| 10:35 ET | 5700 | 3.105 |
| 10:37 ET | 100 | 3.105 |
| 10:39 ET | 1721 | 3.1189 |
| 10:42 ET | 5188 | 3.125 |
| 10:44 ET | 2150 | 3.125 |
| 10:46 ET | 4177 | 3.11 |
| 10:48 ET | 8280 | 3.15 |
| 10:50 ET | 8596 | 3.155 |
| 10:51 ET | 2430 | 3.145 |
| 10:53 ET | 1084 | 3.145 |
| 10:55 ET | 795 | 3.14 |
| 10:57 ET | 4263 | 3.13 |
| 11:00 ET | 6158 | 3.125 |
| 11:02 ET | 1113 | 3.125 |
| 11:04 ET | 4480 | 3.1289 |
| 11:06 ET | 1274 | 3.13 |
| 11:08 ET | 6507 | 3.16 |
| 11:09 ET | 700 | 3.145 |
| 11:11 ET | 4031 | 3.14 |
| 11:13 ET | 1291 | 3.1212 |
| 11:15 ET | 6377 | 3.11 |
| 11:18 ET | 1800 | 3.11 |
| 11:20 ET | 2442 | 3.1099 |
| 11:22 ET | 1852 | 3.105 |
| 11:26 ET | 1900 | 3.1054 |
| 11:27 ET | 700 | 3.105 |
| 11:29 ET | 12153 | 3.105 |
| 11:31 ET | 1645 | 3.1 |
| 11:33 ET | 200 | 3.095 |
| 11:38 ET | 900 | 3.1 |
| 11:42 ET | 600 | 3.0999 |
| 11:44 ET | 4634 | 3.09 |
| 11:45 ET | 7876 | 3.0928 |
| 11:47 ET | 100 | 3.095 |
| 11:49 ET | 100 | 3.095 |
| 11:51 ET | 978 | 3.095 |
| 11:54 ET | 2716 | 3.095 |
| 11:56 ET | 2228 | 3.07 |
| 11:58 ET | 12872 | 3.065 |
| 12:00 ET | 816 | 3.065 |
| 12:02 ET | 8732 | 3.0511 |
| 12:03 ET | 2100 | 3.05 |
| 12:05 ET | 300 | 3.05 |
| 12:07 ET | 31848 | 3.045 |
| 12:09 ET | 2069 | 3.05 |
| 12:12 ET | 12712 | 3.045 |
| 12:16 ET | 100 | 3.045 |
| 12:18 ET | 2116 | 3.05 |
| 12:20 ET | 600 | 3.045 |
| 12:21 ET | 6073 | 3.035 |
| 12:23 ET | 1122 | 3.035 |
| 12:25 ET | 100 | 3.035 |
| 12:27 ET | 37560 | 3.075 |
| 12:30 ET | 2558 | 3.065 |
| 12:32 ET | 2800 | 3.0693 |
| 12:34 ET | 400 | 3.065 |
| 12:36 ET | 2100 | 3.075 |
| 12:38 ET | 2100 | 3.078 |
| 12:39 ET | 7395 | 3.085 |
| 12:41 ET | 1696 | 3.0897 |
| 12:43 ET | 600 | 3.08 |
| 12:45 ET | 100 | 3.09 |
| 12:48 ET | 1300 | 3.09 |
| 12:50 ET | 5431 | 3.0999 |
| 12:52 ET | 100 | 3.095 |
| 12:54 ET | 200 | 3.095 |
| 12:56 ET | 500 | 3.091 |
| 12:57 ET | 600 | 3.095 |
| 12:59 ET | 600 | 3.095 |
| 01:01 ET | 10223 | 3.08 |
| 01:03 ET | 606 | 3.085 |
| 01:06 ET | 800 | 3.0808 |
| 01:08 ET | 817 | 3.085 |
| 01:10 ET | 200 | 3.085 |
| 01:12 ET | 100 | 3.09 |
| 01:14 ET | 300 | 3.085 |
| 01:15 ET | 100 | 3.085 |
| 01:17 ET | 100 | 3.08 |
| 01:21 ET | 2923 | 3.05 |
| 01:24 ET | 863 | 3.0559 |
| 01:26 ET | 363 | 3.055 |
| 01:28 ET | 1336 | 3.055 |
| 01:30 ET | 1060 | 3.054 |
| 01:32 ET | 728 | 3.055 |
| 01:33 ET | 882 | 3.055 |
| 01:35 ET | 2951 | 3.045 |
| 01:37 ET | 400 | 3.05 |
| 01:39 ET | 2045 | 3.055 |
| 01:42 ET | 400 | 3.05 |
| 01:44 ET | 100 | 3.055 |
| 01:46 ET | 100 | 3.051 |
| 01:48 ET | 2415 | 3.05 |
| 01:50 ET | 105 | 3.0411 |
| 01:53 ET | 1100 | 3.045 |
| 01:55 ET | 6141 | 3.055 |
| 02:00 ET | 1596 | 3.06 |
| 02:02 ET | 1900 | 3.065 |
| 02:06 ET | 2800 | 3.0589 |
| 02:09 ET | 100 | 3.06 |
| 02:11 ET | 311 | 3.055 |
| 02:15 ET | 355 | 3.055 |
| 02:18 ET | 100 | 3.055 |
| 02:20 ET | 100 | 3.055 |
| 02:24 ET | 100 | 3.06 |
| 02:31 ET | 7722 | 3.055 |
| 02:33 ET | 300 | 3.06 |
| 02:36 ET | 765 | 3.06 |
| 02:38 ET | 10268 | 3.064 |
| 02:40 ET | 2771 | 3.07 |
| 02:42 ET | 15708 | 3.065 |
| 02:44 ET | 300 | 3.065 |
| 02:45 ET | 21334 | 3.095 |
| 02:49 ET | 270 | 3.098 |
| 02:51 ET | 24782 | 3.095 |
| 02:54 ET | 2597 | 3.0888 |
| 02:58 ET | 200 | 3.09 |
| 03:00 ET | 200 | 3.09 |
| 03:02 ET | 1271 | 3.085 |
| 03:03 ET | 17346 | 3.1 |
| 03:05 ET | 1669 | 3.11 |
| 03:07 ET | 4590 | 3.095 |
| 03:09 ET | 2583 | 3.105 |
| 03:14 ET | 200 | 3.11 |
| 03:16 ET | 2030 | 3.11 |
| 03:18 ET | 4067 | 3.12 |
| 03:20 ET | 465 | 3.115 |
| 03:21 ET | 8613 | 3.1099 |
| 03:23 ET | 2201 | 3.105 |
| 03:25 ET | 334 | 3.105 |
| 03:27 ET | 1887 | 3.1012 |
| 03:30 ET | 100 | 3.105 |
| 03:32 ET | 100 | 3.105 |
| 03:34 ET | 10600 | 3.095 |
| 03:36 ET | 730 | 3.095 |
| 03:38 ET | 100 | 3.1 |
| 03:39 ET | 10976 | 3.095 |
| 03:41 ET | 1880 | 3.095 |
| 03:43 ET | 7856 | 3.085 |
| 03:45 ET | 3768 | 3.09 |
| 03:48 ET | 4719 | 3.095 |
| 03:50 ET | 367 | 3.095 |
| 03:52 ET | 16354 | 3.095 |
| 03:54 ET | 14317 | 3.094 |
| 03:56 ET | 10051 | 3.105 |
| 03:57 ET | 27135 | 3.1 |
| 03:59 ET | 87857 | 3.12 |
Sep 16, 2024
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm, from 11:42AM ET on Monday Sep 16, 2024 by Dow Jones
11:42AM ET on Monday Sep 16, 2024 by Dow Jones
Aug 28, 2024
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences, from 8:30AM ET on Wednesday Aug 28, 2024 by Dow Jones
8:30AM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 204.9M | -1.3x | --- |
Amarin Corporation PLC | 239.6M | -6.9x | --- |
Organogenesis Holdings Inc | 385.8M | -22.2x | --- |
Ironwood Pharmaceuticals Inc | 642.2M | 91.0x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Coherus BioSciences Inc | 115.2M | -2.5x | --- |
Company Information
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Contact Information
- Headquarters
- 43 THORNDIKE STREETCAMBRIDGE, MA, United States 02141
- Phone
- 617-682-0917
- Fax
- 302-636-5454
Executives
- Chair of the Board of Directors
- George Milne
- Co-Chief Executive Officer, Director
- Joshua Cohen
- Co-Chief Executive Officer, Director
- Justin Klee
- Chief Financial Officer
- James Frates
- Chief Legal Officer and General Counsel
- Gina Mazzariello
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $204.9M |
|---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
